Vitasek 269436 v. GEO Group Incorporated

CourtDistrict Court, D. Arizona
DecidedMay 30, 2025
Docket2:24-cv-00155
StatusUnknown

This text of Vitasek 269436 v. GEO Group Incorporated (Vitasek 269436 v. GEO Group Incorporated) is published on Counsel Stack Legal Research, covering District Court, D. Arizona primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Vitasek 269436 v. GEO Group Incorporated, (D. Ariz. 2025).

Opinion

1 WO 2 3 4 5 6 IN THE UNITED STATES DISTRICT COURT 7 FOR THE DISTRICT OF ARIZONA

9 Arthur L Vitasek, No. CV-24-00155-PHX-SHD (JZB)

10 Plaintiff, ORDER

11 v.

12 GEO Incorporated, et al.,

13 Defendants. 14 15 Pending before the Court are Plaintiff’s “Motion to Approve Subpoena (Correct 16 Rx Pharmacy),” which the Court construes as a motion to compel (“First Motion to 17 Compel”) (doc. 63); Plaintiff’s “Motion to Approve Subpoena (Incident Reports),” which 18 the Court also construes as a motion to compel (“Second Motion to Compel”) (doc. 65); 19 Plaintiff’s motion to compel Defendants’ insurance agreements, Defendant GEO Group’s 20 email correspondence and digital files pertaining to Plaintiff, and Plaintiff’s call log 21 (“Third Motion to Compel”) (doc. 68); Plaintiff’s “Motion to Compel the Defendants’ 22 Initial Discovery Disclosures” (“Fourth Motion to Compel”) (doc. 73); Plaintiff’s motion 23 to compel Defendants’ curricula vitae (“Fifth Motion to Compel”) (doc. 75); Plaintiff’s 24 “Motion for Entry of Default as to Christine Armenta for Failing to Answer 25 Interrogatories” (“First Motion for Default”) (doc. 74); Plaintiff’s “Motion for Entry of 26 Default as to Courtney Pochopien for Failure to Respond to Discovery” (“Second Motion 27 for Default”) (doc. 78); Plaintiff’s motion for entry of default as to Defendant Armenta 28 for failing to timely serve responses to Plaintiff’s requests for admissions (“Third Motion 1 for Default”) (doc. 79); Plaintiff’s motion for entry of default as to Defendant GEO 2 Group for failing to timely respond to Plaintiff’s requests for admissions (“Fourth Motion 3 for Default”) (doc. 81); Plaintiff’s motion for entry of default as to Defendant Pochopien 4 for failing to respond to Plaintiff’s written interrogatories within 30 days (doc. 82) (“Fifth 5 Motion for Default”); Plaintiff’s “Motion to Strike Defendant Courtney Pochopien’s 6 Response to Plaintiff’s Request for Admissions” (“Motion to Strike”) (doc. 88); and 7 Plaintiff’s “Motion to Withdraw Plaintiff’s Alternative to Strike Pochopien’s Request for 8 Admissions” (“Motion to Withdraw”) (doc. 93). The Court will first provide a brief 9 factual background to the case and address Plaintiff’s various motions to compel. 10 I. Background. 11 Plaintiff’s First Amended Complaint (“FAC”) is the operative complaint. (Doc. 6.) 12 On October 21, 2024, the Court screened the FAC. (Doc. 11.) The Court permitted 13 Plaintiff’s Count One—an Eighth Amendment deliberate indifference claim—to proceed 14 against Defendants GEO Group and Armenta. (Id. at 10.) The Court permitted Plaintiff’s 15 Count Two—a First Amendment retaliation claim—to proceed against Defendant 16 Pochopien. (Id. at 11.) 17 A. Count One. 18 Plaintiff’s deliberate indifference claim involves GEO Group and Armenta’s 19 failure to properly treat Plaintiff’s Dupuytren’s Contracture—a condition causing 20 progressively thickening and painful “cords” in his hands and contractures in his smaller 21 digits also resulting in numbness and difficulties completing daily activities. (See Doc. 11 22 at 3-7.)1 Plaintiff was seen by an outside specialist in November 2020 who prescribed 23 Xiaflex—a medication that is injected into the hand that helps dissolve the cords. (Id. at 24 4.) Plaintiff states the pharmacist at the GEO facility refused to authorize the medication 25 due to cost. (Id.) Plaintiff’s physician stated that, instead, Plaintiff would need tendon 26 release surgery and vitamin E to help break down the cords, but that the GEO Group

27 1 Dupuytren’s contracture is “a disease of the palmar fascia resulting in thickening and shortening of fibrous bands on the palmar surface of the hand and fingers, resulting in a 28 characteristic flexion deformity of the fourth and fifth digits.” Dupuytren contracture, Stedman’s Medical Dictionary 201260. 1 nurse refused to prescribe the vitamin E at the dosage the doctor recommended. (Id.) 2 Plaintiff states this is a systemic problem at GEO Group, where nurses unilaterally 3 change doctor’s orders. (Id.) Plaintiff alleges he was scheduled to see a hand specialist, 4 but the 2019 COVID pandemic began, and the process shut down. (Id.) 5 In 2022, Plaintiff began to press the issue because his condition was worsening. 6 (Id.) A licensed practical nurse ordered x-rays. (Id. at 5.) On October 31, 2022, Plaintiff’s 7 hands and wrists became completely numb and he began to worry about nerve damage. 8 (Id.) On November 1, 2022, Plaintiff’s physician advised Plaintiff was due to have 9 surgery, but on November 2nd, Defendant Armenta stated there would be no further 10 treatment for Plaintiff’s condition. (Id.) The ensuing grievance process was unsuccessful. 11 (Id. at 5-6.) 12 Plaintiff alleges a systemic defect in GEO Group facilities which allows staff 13 nurses to overrule or bypass the recommendations of outside specialist physicians. (Id.) 14 Plaintiff states this is done to save money. (Id.) Plaintiff alleges that, once he was moved 15 back to an ADCRR facility, his surgery was scheduled and performed, but that he was 16 left with permanent scars and residual nerve damage which could have been prevented. 17 (Id. at 6.) Plaintiff states that had Xiaflex been approved, surgery could have been 18 avoided. (Id.) 19 B. Count Two. 20 Plaintiff alleges that after Defendant Armenta denied treatment in November 21 2022, Plaintiff filed a grievance against her. (Id. at 7.) A week later, Plaintiff saw 22 Defendant Pochopien, Defendant Armenta’s colleague, who also refused treatment for 23 Plaintiff’s hands. (Id. at 8.) Later that day, a captain at the facility told Plaintiff that 24 Pochopien wanted him to write Plaintiff a disciplinary ticket because Plaintiff had 25 threatened Pochopien by threatening to call his wife. (Id.) Plaintiff states the captain did 26 not write the ticket, but Pochopien wrote a false report anyway and put it in Plaintiff’s 27 medical file. (Id.) 28 // 1 II. Motions to Compel. 2 District courts have broad discretion to permit or deny discovery. Hallett v. 3 Morgan, 296 F.3d 732, 751 (9th Cir. 2002). A motion to compel discovery “must include 4 a certification that the movant has in good faith conferred or attempted to confer with the 5 person or party failing to make disclosure or discovery in an effort to obtain it without 6 court action.” Fed. R. Civ. P. 37(a)(1); LRCiv 7.2(j); see also Lathan v. Ducart, F. App’x 7 379 (9th Cir. 2017) (“The district court did not abuse its discretion by denying 8 [plaintiff’s] motion to compel discovery because [plaintiff] failed to meet and confer with 9 defendants.”) (citation omitted). Furthermore, Rule 37.1 of the Local Rules of Civil 10 Procedure provides that a motion to compel discovery: 11 shall set forth, separately from a memorandum of law, the following in separate, distinct, numbered paragraphs: 12 (1) the question propounded, the interrogatory submitted, the 13 designation requested or the inspection requested; 14 (2) the answer, designation or response received; and 15 (3) the reason(s) why said answer, designation or response is deficient. 16 17 LRCiv 37.1(a). 18 A. Plaintiff’s First Motion to Compel (doc. 63). 19 Plaintiff states he propounded Requests for Production to Defendants in January 20 2025, and that “Defendants responded negatively on every request.” (Doc. 63 at 1.) 21 Plaintiff states he conferred with counsel for Defendants on March 10, 2025, and that 22 Defendants refused to provide discovery. (Id.)2 In Plaintiff’s initial request, he sought to 23 issue a subpoena to a third-party, Correct Rx Pharmacy Services, Inc., to obtain the 24 “policies, practices, procedures, and contractual agreements with GEO Group, Inc., 25 concerning the ‘cost v. benefit’ ratio Correct Rx Pharmacy, Inc. uses to deny a patient’s 26 medicine/treatment needs.” (Id.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Vitasek 269436 v. GEO Group Incorporated, Counsel Stack Legal Research, https://law.counselstack.com/opinion/vitasek-269436-v-geo-group-incorporated-azd-2025.